HealthGermany1 sourcesNeutral

BioArctic: New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD congress

STOCKHOLM, March 23, 2026 /PRNewswire/ -- BioArctic's AB (publ) (STOCKHOLM: BIOA B ) partner Eisai presented new data at the 2026 International Conference on Alzheimer's and Parkinson's Diseases a...

Finanznachrichten.de

via Finanznachrichten.de

March 23, 2026 | 8:00 AM UTCUpdated 1h ago

Share Read original

Read the full article at Finanznachrichten.de →

BioArctic: New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD congress

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Finanznachrichten.de

NewsDataDE

Comments

0 comments

Be respectful and constructive.

Loading comments...

Our nursery called 8 times in 10 weeks — it's the hidden plight of working parents - Metro.co.uk

Google News-13h ago-1 sources

BioArctic: New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD congress

Source Verification

Comments

‘Taskmaster’ Host Greg Davies To Present BAFTA Television Awards

Man dies after choking in bun eating contest

Related Articles

Advocate flags communication gap for deaf Jamaicans

Push for policies to boost medication adherence

Our nursery called 8 times in 10 weeks — it's the hidden plight of working parents - Metro.co.uk